Loading clinical trials...

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT04693429

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+

Clinical phase I, controlled, non comparative, open, single center study evaluating the safety and tolerability of ophthalmic solution PRO-172 when applied on the ocular surface of healthy volunteers.

Lead sponsor: Laboratorios Sophia S.A de C.V.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 3

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group

NCT05937750 · Long Term Efficacy and Safety

RECRUITINGNA

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger

NCT07256522 · Trigger Finger, Splint Therapy, and more

RECRUITING

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

NCT04354545 · Glaucoma, Ocular Surface Disease

RECRUITINGEARLY Phase 1

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

NCT04592640 · Chronic Kidney Diseases, Calciphylaxis, and more

RECRUITINGPhase 1

Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

NCT07179848 · Health Adults, Temporal Interference Stimulation, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 16, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment22

Start dateSep 2020

Last updatedJul 16, 2025

Condition

Safety Tolerability Ocular Surface Ocular Comfort

Locations shown

Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.

Guadalajara, Jalisco

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 16, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions